Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sunit Sarkar"'
Autor:
Tanmoy Chakraborty, Apurba Das, Bhabatosh Biswas, Sunit Sarkar, Nillohit Mukherjee, Arijit Sinha, Shubhabrata Datta
Publikováno v:
Proceedings of the Institution of Mechanical Engineers, Part E: Journal of Process Mechanical Engineering. 236:1869-1876
A synthetic composite material membrane was synthesized using Polyether ether ketone (PEEK) as a polymer matrix, reinforced with nano-Hydroxyapatite (nHAp) as the ceramic for intended use as a hip bone implant material. Notwithstanding its close rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c44892c18150ebd2600e184e2e4d984e
https://doi.org/10.1177/09544089221076799
https://doi.org/10.1177/09544089221076799
Autor:
Michael Lam, Philip J. Hogg, David Edmonds, Lisa G. Horvath, Jayesh Desai, Peter Grimison, Anne Hamilton, Peter Savas, Sunit Sarkar, Danny Rischin, James R. Whittle, Ben Tran, Nicole Signal, James C Kuo
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87:613-620
This phase I study was conducted to evaluate the safety and Maximum Tolerated Dose of PENAO (4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid), a second-generation organic arsenical with anti-mitochondrial activity, when given as a continuous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73addb845b1fde092147082b8124910b
https://doi.org/10.1007/s00280-020-04225-7
https://doi.org/10.1007/s00280-020-04225-7
Publikováno v:
Cancer Research. 83:P3-01
Background: Oncologists are often asked to provide information about expected survival times for patients with metastatic breast cancer (MBC). We have previously demonstrated that using estimates of best-case, typical and worst-case scenarios for sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da7d8e63dc1ae4994514bca0ad8fcfa6
https://doi.org/10.1158/1538-7445.sabcs22-p3-01-10
https://doi.org/10.1158/1538-7445.sabcs22-p3-01-10
Autor:
Sunit, Sarkar, Ben, Tran, Lisa, Horvath, Michael, Lam, Peter, Savas, Peter, Grimison, James R, Whittle, James C, Kuo, Nicole, Signal, David, Edmonds, Philip, Hogg, Danny, Rischin, Jayesh, Desai, Anne, Hamilton
Publikováno v:
Cancer chemotherapy and pharmacology. 87(5)
This phase I study was conducted to evaluate the safety and Maximum Tolerated Dose of PENAO (4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid), a second-generation organic arsenical with anti-mitochondrial activity, when given as a continuous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1f9dfc9671d4544a4e3dc28dd8cee54
https://pubmed.ncbi.nlm.nih.gov/33496801
https://pubmed.ncbi.nlm.nih.gov/33496801